Okay, let's tackle this question about the most suitable iodine radioisotope for treating hyperthyroidism. First, I need to remember which iodine isotopes are used in medical treatments. I know that iodine is taken up by the thyroid, so the right isotope should emit radiation that can destroy thyroid tissue without being too harmful to surrounding areas.

The options probably include I-131, I-123, and maybe others like I-125. I recall that I-131 is used for both diagnosis and treatment, but wait, maybe there's a specific reason why one is better than the other. I-131 emits beta particles, which have a short range, making it suitable for destroying thyroid cells. I-123 is mainly used for imaging because it emits gamma rays and has a shorter half-life, which is safer for diagnostic purposes. So the treatment would need a beta emitter with a longer half-life to allow for proper uptake and destruction.

Wait, the question is about hyperthyroidism treatment. So the answer should be I-131. The other isotopes like I-123 are gamma emitters and used for scans, not treatment. I-125 might be used in other contexts, maybe brachytherapy, but not for hyperthyroidism. Let me confirm: I-131 is indeed the standard for hyperthyroidism because it's taken up by the thyroid and the beta radiation damages the cells. The gamma rays from I-131 also help in imaging, but the main therapeutic effect is from the beta particles. So the correct answer must be I-131. The wrong options would be other isotopes that don't have the right emission type or half-life for treatment.

**Core Concept**
The question assesses knowledge of therapeutic radioisotopes targeting thyroid tissue. Iodine isotopes are selectively taken up by thyroid follicular cells, where their radiation destroys overactive tissue in hyperthyroidism. The ideal isotope emits beta particles (short range) for localized damage and gamma rays (long range) for imaging/dose monitoring.

**Why the Correct Answer is Right**
**Iodine-131 (I-131)** is the gold standard for hyperthyroidism treatment. It emits **beta particles (β⁻)** with a short penetration range (0.5–2 mm), effectively ablating thyroid tissue without damaging adjacent structures. Its gamma emissions (364 keV) also allow post-treatment imaging to confirm uptake. The half-life (8 days) balances sufficient time for thyroid uptake with timely decay, minimizing systemic exposure.

**Why Each Wrong Option is Incorrect**
**Option A:** *Iodine-123 (I-123)* emits pure gamma rays (159 keV) and has a short half-life (13 hours). While used for diagnostic imaging (e.g., thyroid scans), it lacks therapeutic beta activity.
**Option C:** *Iodine-125 (I-125)* emits low-energy beta particles (0.4–1.3 MeV) and is primarily used in brachytherapy or seed implants, not systemic hyperthyroidism treatment.
**Option D:** *Iodine-127* is stable and non

✓ Correct Answer: C. I131